Status: Approved
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Anemia; Kidney Diseases; Kidney Failure, Chronic Phase 2 ClinicalTrials
Anemia; Kidney Diseases; Kidney Failure, Chronic; Renal Insufficiency, Chronic Phase 2/Phase 3 ClinicalTrials
Anemia; Kidney Diseases; Renal Insufficiency, Chronic Phase 2 ClinicalTrials
Anemia; Kidney Diseases; Renal Insufficiency, Chronic Phase 3 ClinicalTrials
Anemia; Myelodysplastic Syndromes Phase 3 ClinicalTrials
Anemia; Kidney Diseases; Renal Insufficiency, Chronic Phase 3 ClinicalTrials
Kidney Diseases; Kidney Failure, Chronic Phase 2 ClinicalTrials
Anemia; Kidney Diseases; Kidney Failure, Chronic; Renal Insufficiency; Renal Insufficiency, Chronic Phase 2 ClinicalTrials
Anemia; Kidney Diseases; Renal Insufficiency, Chronic Phase 3 ClinicalTrials
Anemia Phase 3 ClinicalTrials
Hepatic Insufficiency; Liver Failure Phase 1 ClinicalTrials
Anemia; Kidney Diseases; Renal Insufficiency, Chronic Phase 2 ClinicalTrials
Anemia; Renal Insufficiency Phase 1 ClinicalTrials
Anemia; Myelodysplastic Syndromes Phase 2/Phase 3 ClinicalTrials
Anemia; Kidney Diseases; Renal Insufficiency, Chronic Phase 2 ClinicalTrials
Anemia Phase 2 ClinicalTrials
Anemia; Kidney Diseases; Renal Insufficiency, Chronic Phase 4 ClinicalTrials
Anemia; Kidney Diseases; Renal Insufficiency, Chronic Phase 2 ClinicalTrials
Anemia; Kidney Diseases; Renal Insufficiency, Chronic Phase 3 ClinicalTrials
CONTENTS